
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Clinical Ink, provider of eSource and patient engagement technologies, and Integron, provider of managed services for the connected health and Internet of Things (IoT) industry, announced a partnership to extent Clinical Ink's capabilites in mobile device and sensor deployment, in order to engage and collect data from patients in clinical trials.
Read the full release






